News

Laurent Pharmaceuticals announces initiation of a Phase 1 clinical study of Fenretinide in Cystic Fibrosis

20 May 2014

Laurent Pharmaceuticals Inc. announced today that the Research Institute of the McGill University Health Centre (RI-MUHC) has started enrolling patients in...

Read More

EVENTS

Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA

read more
Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA
read more
Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022
read more
Laurent Pharma to participate to BiotechGate, February 7-9, 2022
read more
Laurent Pharma to participate to Biotech Showcase, January 9-11 and 17-19, 2022
Laurent Pharma to participate to H.C. Wainwright 23rd Annual Global Investment Conference,
September 13-15, 2021
read more